Global Biologics Cell & Gene Legal Summit

Get Tickets Here

Generic, biosimilar and innovator biopharma companies are in different positions and will need to react differently to these changing market circumstances. Additionally, the face of biologics is changing with and increasing number of gene therapy and antibody-drug conjugate options adding to and sometimes taking the place of “naked antibodies”. The Global Biologics, Cell and Gene Summit is perfect place to address these changes with leading industry experts from across the IP, Regulatory and Commercial fields.